Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec 1:578:112067.
doi: 10.1016/j.mce.2023.112067. Epub 2023 Sep 7.

Nanoparticles at the maternal-fetal interface

Affiliations
Review

Nanoparticles at the maternal-fetal interface

S Adams et al. Mol Cell Endocrinol. .

Abstract

The increasing production of intentional and unintentional nanoparticles (NPs) has led to their accumulation in the environment as air and ground pollution. The heterogeneity of these particles primarily relies on the NP physicochemical properties (i.e., chemical composition, size, shape, surface chemistry, etc.). Pregnancy represents a vulnerable life stage for both the woman and the developing fetus. The ubiquitous nature of these NPs creates a concern for developmental fetal exposures. At the maternal-fetal interface lies the placenta, a temporary endocrine organ that facilitates nutrient and waste exchange as well as communication between maternal and fetal tissues. Recent evidence in human and animal models identifies that gestational exposure to NPs results in placental translocation leading to local effects and endocrine disruption. Currently, the mechanisms underlying placental translocation and cellular uptake of NPs in the placenta are poorly understood. The purpose of this review is to assess the current understanding of the physiochemical factors influencing NP translocation, cellular uptake, and endocrine disruption at the maternal-fetal interface within the available literature.

Keywords: Endocrine; Maternal-fetal interface; Nanoparticle; Physicochemical properties; Placenta; Uptake/translocation.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The increasing production of intentional and unintentional nanoparticles (NPs) has led to their accumulation in the environment as air and ground pollution. The heterogeneity of these particles primarily relies on the NP physicochemical properties (i.e., chemical composition, size, shape, surface chemistry, etc.). Pregnancy represents a vulnerable life stage for both the woman and the developing fetus. The ubiquitous nature of these NPs creates a concern for developmental fetal exposures. At the maternal fetal interface lies the placenta, a unique and transient endocrine organ that facilitates nutrient and waste exchange as well as communication between maternal and fetal tissues. Recent evidence in human and animal models identify that gestational exposure to NPs results in placental translocation leading to local effects and endocrine disruption. Currently, the mechanisms underlying placental translocation and cellular uptake of NPs in the placenta is poorly understood. The purpose of this review is to assess the current understanding of the physiochemical factors influencing NP translocation, cellular uptake, and endocrine disruption at the maternal-fetal interface within the available literature.

Figures

Fig. 1.
Fig. 1.
Discoid, hemochorial placental anatomy.
Fig. 2.
Fig. 2.
Summary of cellular interactions that occur in the placenta, following gestational exposure to NPs. Created using BioRender.

References

    1. Abdelkhaliq A, van der Zande M, Peters RJB, Bouwmeester H, 2020. Combination of the BeWo b30 placental transport model and the embryonic stem cell test to assess the potential developmental toxicity of silver nanoparticles. Part. Fibre Toxicol 17, 11. - PMC - PubMed
    1. Abostait A, Tyrrell J, Abdelkarim M, Shojaei S, Tse WH, El-Sherbiny IM, Keijzer R, Labouta HI, 2022. Placental nanoparticle uptake-on-a-chip: the impact of trophoblast syncytialization and shear stress. Mol. Pharm 19, 3757–3769. - PubMed
    1. Adamcakova-Dodd A, Monick MM, Powers LS, Gibson-Corley KN, Thorne PS, 2015. Effects of prenatal inhalation exposure to copper nanoparticles on murine dams and offspring. Part. Fibre Toxicol 12, 30. - PMC - PubMed
    1. Additives E, Aquilina G, Castle L, Engel K-H, Fowler P, Frutos Fernandez MJ, Fürst P, Gundert-Remy U, Gürtler R, Husøy T, Manco M, Mennes W, Moldeus P, Passamonti S, Panel, o.F., Flavourings, Younes M, Shah R, WaalkensBerendsen I, Wölfle D, Corsini E, Cubadda F, De Groot D, FitzGerald R, Gunnare S, Gutleb AC, Mast J, Mortensen A, Oomen A, Piersma A, Plichta V, Ulbrich B, Van Loveren H, Benford D, Bignami M, Bolognesi C, Crebelli R, Dusinska M, Marcon F, Nielsen E, Schlatter J, Vleminckx C, Barmaz S, Carfí M, Civitella C, Giarola A, Rincon AM, Serafimova R, Smeraldi C, Tarazona J, Tard A, Wright M, 2021. Safety assessment of titanium dioxide (E171) as a food additive. EFSA J. 19, e06585. - PMC - PubMed
    1. Aengenheister L, Dietrich D, Sadeghpour A, Manser P, Diener L, Wichser A, Karst U, Wick P, Buerki-Thurnherr T, 2018. Gold nanoparticle distribution in advanced in vitro and ex vivo human placental barrier models. J. Nanobiotechnol 16, 79. - PMC - PubMed

Substances

LinkOut - more resources